Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|February 12, 2015
Pharmacogenetics of opioid responseA A Somogyi, J K Coller, D T Barratt
British Journal of Clinical Pharmacology|July 27, 1999
Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoformsJ K Coller, A A Somogyi, F Bochner
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 26, 1999
Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4J K Coller, A A Somogyi, F Bochner
British Journal of Clinical Pharmacology|June 1, 1997
Association between CYP2C19 genotype and proguanil oxidative polymorphismJ K Coller, A A Somogyi, F Bochner
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2004
A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysisH M James, J K Coller, D Gillis, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 30, 2007
Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadoneJ K Coller, C Joergensen, D J R Foster, et al.
British Journal of Anaesthesia|September 22, 2018
Persistent postoperative pain after total knee arthroplasty: a prospective cohort study of potential risk factorsD A Rice, M T Kluger, P J McNair, et al.
Anaesthesia|June 28, 2022
Factors associated with persistent opioid use 6-12 months after primary total knee arthroplastyM T Kluger, D A Rice, R Borotkanics, et al.
Pageof 10